Recruitment

Recruitment Status
Completed
Estimated Enrollment
Same as current

Summary

Conditions
  • Amino Acid
  • Growth Hormone
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Basic Science

Participation Requirements

Age
Between 18 years and 70 years
Gender
Both males and females

Description

Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.

Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.

Tracking Information

NCT #
NCT01540773
Collaborators
Not Provided
Investigators
Principal Investigator: Frank Greenway, MD Pennington Biomedical Research Center